NASDAQ: RYTM - Rhythm Pharmaceuticals, Inc.

Rentabilidade por seis meses: +19.85%
Rendimento de dividendos: 0.00%
Setor: Healthcare

Cronograma de promoção Rhythm Pharmaceuticals, Inc.


Sobre a empresa Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals, Inc., биофармацевтическая компания на коммерческой стадии, занимается разработкой и коммерциализацией терапевтических средств для лечения редких генетических заболеваний ожирения. Ведущим продуктом компании является IMCIVREE, редкий рецептор меланокортина-4 для лечения проопиомеланокортина (POMC), пропротеинконвертазы субтилизина/кексина типа 1, дефицита рецептора лептина (LEPR), ожирения и синдрома Бардета-Бидля и Альстрема.

mais detalhes
Он также разрабатывает сетмеланотид, который находится в фазе 3 клинических испытаний для лечения ожирения с гетерозиготным дефицитом POMC или LEPR, ожирения с дефицитом коактиватора стероидных рецепторов 1, ожирения с дефицитом SH2B1, ожирения с дефицитом рецептора MC4 и других нарушений MC4R. Компания, ранее известная как Rhythm Metabolic, Inc., сменила название на Rhythm Pharmaceuticals, Inc. в октябре 2015 года. Rhythm Pharmaceuticals, Inc. была основана в 2008 году, ее штаб-квартира находится в Бостоне, штат Массачусетс.

IPO date 2017-10-05
ISIN US76243J1051
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://rhythmtx.com
Цена ао 54.89
Alteração de preço por dia: 0% (57.78)
Alteração de preço por semana: +5.94% (54.54)
Alteração de preço por mês: +2.19% (56.54)
Alteração de preço em 3 meses: +16.89% (49.43)
Mudança de preço em seis meses: +19.85% (48.21)
Mudança de preço por ano: +28.49% (44.97)
Mudança de preço em 3 anos: +691.51% (7.3)
Mudança de preço em 5 anos: +151.44% (22.98)
Mudança de preço em 10 anos: 0% (57.78)
Mudança de preço desde o início do ano: +3.46% (55.85)

Subestimação

Nome Significado Nota
P/S 34.52 1
P/BV 15.75 1
P/E 0 0
EV/EBITDA -15.52 0
Total: 2.88

Eficiência

Nome Significado Nota
ROA, % -55.5 0
ROE, % -108.79 0
Total: 0

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0

Obrigação

Nome Significado Nota
Debt/EBITDA -0.0075 10
Total: 9.8

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 221122.86 10
Rentabilidade Ebitda, % 15.39 3
Rentabilidade EPS, % -13.37 0
Total: 3.8

ETF Compartilhar, % Rentabilidade para o ano, % Dividendos, %
Innovator IBD 50 ETF 2.98878 31.06 0.08939
Virtus LifeSci Biotech Products ETF 1.78135 36.79 0.13953
Harbor Human Capital Factor US Small Cap ETF 1.47928 28.89 0.44
IQ Healthy Hearts ETF 0.68633 16.74 1.95958
First Trust Nasdaq Pharmaceuticals ETF 0.59089 18.37 2.19901
Invesco Dorsey Wright SmallCap Momentum ETF 0.43553 33.91 0.61241
First Trust Small Cap Growth AlphaDEX Fund 0.42871 42.5 1.22182
Direxion Daily S&P Biotech Bull 3x Shares 0.32797 4067.92 0.25924
Invesco Nasdaq Biotechnology ETF 0.31983 28.58 0.8565
Future Tech ETF 0.31232 426.34 0.8416
Principal Healthcare Innovators ETF 0.31232 618.5 0.8416
First Trust Multi-Manager Small Cap Opportunities ETF 0.25924 48.51 0.31756
First Trust Small Cap Core AlphaDEX Fund 0.22767 17.31 1.87983
ProShares Ultra Nasdaq Biotechnology 0.21727 51.7 0.85651
iShares Russell 2000 Growth ETF 0.21372 38.04 0.6026
Principal U.S. Small-Cap ETF 0.2131 16.7 1.20466
Vanguard Russell 2000 Growth ETF 0.19 23.05 0.60264
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.18041 24.75 1.59225
BNY Mellon US Small Cap Core Equity ETF 0.12197 30.07 1.75333
iShares Morningstar Small-Cap Growth ETF 0.11467 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.11467 587.89 0.72598
Vanguard U.S. Momentum Factor ETF 0.11 30.05 1.05834
Vanguard Russell 2000 ETF 0.1 17.16 1.48801
First Trust Multi Cap Growth AlphaDEX Fund 0.09278 41.56 1.02425
Schwab U.S. Small-Cap ETF 0.06852 17.47 1.51433
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.06774 31.36 1.41955
ProShares UltraPro Russell2000 0.06246 89.82 1.47873
iShares Morningstar Small-Cap ETF 0.05766 391.25 1.60498
iShares Morningstar Small-Cap ETF 0.05766 30.1 1.60498
Fidelity MSCI Health Care Index ETF 0.03468 3 1.46057
ProShares Hedge Replication ETF 0.01801 5.92 1.47892
SPDR Portfolio MSCI Global Stock Market ETF 0.01346 17.99 2.19607
Humankind US Stock ETF 0.01192 18.81 1.99919
iShares Russell 3000 ETF 0.00483 24.83 1.43482
Schwab U.S. Broad Market ETF 0.00476 24.86 1.43354
Vanguard Russell 3000 ETF 0 31.87 1.43817



Supervisor Cargo Pagamento Ano de nascimento
Dr. David P. Meeker M.D. Chairman, President & CEO 1.17M 1954 (71 ano)
Mr. Hunter C. Smith M.B.A. CFO & Treasurer 692.2k 1969 (56 anos)
Mr. Joseph Shulman Chief Technical Officer 608.2k 1976 (49 anos)
Mr. Yann Mazabraud Executive VP & Head of International 747.43k 1973 (52 ano)
Mr. David Connolly Head of Investor Relations & Corporate Communications N/A
Mr. Jim Flaherty Senior VP & General Counsel N/A
Ms. Sarah Ryan Vice President of Sales & Marketing N/A
Mr. Christopher German Corporate Controller, Principal Accounting Officer & Executive Director N/A 1971 (54 ano)
Ms. Jennifer Lee Executive VP & Head of North America 644.2k 1976 (49 anos)
Dr. Alastair Garfield Ph.D. Chief Scientific Officer

Endereço: United States, Boston. MA, 222 Berkeley Street - abrir no Google Maps, abrir mapas Yandex
Site: https://rhythmtx.com